Variables | cTACE | DEB-TACE | p-value |
---|---|---|---|
Total | (n = 201) | (n = 72) |  |
 Survival status |  |  | 0.045 |
  Died within ≤5 years follow-up | 153 (76.1) | 48 (66.7) |  |
  Died after more than 5 years follow-up | 10 (5.0) | 1 (1.4) |  |
  Survived until last follow-up | 38 (18.9) | 23 (31.9) |  |
 Progression status |  |  | 0.218 |
  Progression | 192 (95.5) | 66 (91.7) |  |
  Loss of follow-up/censored | 9 (4.5) | 6 (8.3) |  |
 Survival time, months | 37 (32.2, 41.8) | 37 (23.5, 50.5) | 0.091 |
 Progression time, months | 11.0 (9.6, 12.4) | 16.0 (13.1, 18.9) | 0.019 |
BCLC stage = A | (n = 73) | (n = 16) |  |
 Survival status |  |  | 0.083 |
  Died within ≤5 years follow-up | 57 (78.1) | 9 (56.3) |  |
  Died after more than 5 years follow-up | 3 (4.1) | 0 (0) |  |
  Survived until last follow-up | 13 (17.8) | 7 (43.8) |  |
 Progression status |  |  | 0.219 |
  Progression | 70 (95.9) | 14 (87.5) |  |
  Loss of follow-up/censored | 3 (4.1) | 2 (12.5) |  |
 Survival time, months | 42 (36.1, 47.9) | 45 (0, 90.1) | 0.149 |
 Progression time, months | 12 (10.5, 13.5) | 19 (17.8, 20.2) | 0.217 |
BCLC stage = B + C | (n = 128) | (n = 56) |  |
 Survival status |  |  | 0.270 |
  Died within ≤5 years follow-up | 96 (75) | 39 (69.6) |  |
  Died after more than 5 years follow-up | 7 (5.5) | 1 (1.8) |  |
  Survived until last follow-up | 25 (19.5) | 16 (28.6) |  |
 Progression status |  |  | 0.495 |
  Progression | 122 (95.3) | 52 (92.9) |  |
  Loss of follow-up/censored | 6 (4.7) | 4 (7.1) |  |
 Survival time, months | 33 (27.1, 38.9) | 36 (21.3, 50.7) | 0.191 |
 Progression time, months | 10 (8.1, 11.9) | 15 (12.4, 17.7) | 0.032 |